rs72648945
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001267550.2(TTN):āc.17806A>Gā(p.Ile5936Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,613,218 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.17806A>G | p.Ile5936Val | missense_variant | 61/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.17806A>G | p.Ile5936Val | missense_variant | 61/363 | 5 | NM_001267550.2 | ENSP00000467141 | P1 | |
TTN-AS1 | ENST00000659121.1 | n.503-3777T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152146Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000892 AC: 22AN: 246582Hom.: 1 AF XY: 0.000105 AC XY: 14AN XY: 133766
GnomAD4 exome AF: 0.000120 AC: 176AN: 1461072Hom.: 2 Cov.: 40 AF XY: 0.000121 AC XY: 88AN XY: 726780
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74298
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 28, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 10, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 24, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 15, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 10, 2014 | Variant classified as Uncertain Significance - Favor Benign. The Ile4692Val vari ant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 4/8184 European American chromosomes and by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs72648945). Isoleucine (Ile) at position 4692 is not conserved in evolutionarily distant sp ecies and 15 birds and 2 reptiles carry a valine (Val) at this position, raising the possibility that a change at this position may be tolerated. In summary, wh ile the clinical significance of the Ile4692Val variant is uncertain, conservati on data suggest that it is more likely to be benign. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at